NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival

Glioblastomas (GBMs) are lethal brain cancers that are resistant to current therapies. We investigated the cytotoxicity of human allogeneic NK cells against patient-derived GBM in vitro and in vivo, as well as mechanisms mediating their efficacy. We demonstrate that KIR2DS2 immunogenotype NK cells w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol
Autors principals: Gras Navarro, Andrea, Kmiecik, Justyna, Leiss, Lina, Zelkowski, Mateusz, Engelsen, Agnete, Bruserud, Øystein, Zimmer, Jacques, Enger, Per Øyvind, Chekenya, Martha
Format: Artigo
Idioma:Inglês
Publicat: AAI 2014
Matèries:
Tumor Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259203/
https://ncbi.nlm.nih.gov/pubmed/25381437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1400859
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars